In Brief This Week: IntelligentMDx; Techne; Qiagen; Horizon Discovery; Penn Genome Frontiers Institute | GenomeWeb

NEW YORK (GenomeWeb News) – IntelligentMDx has received the CE Mark for its herpes simplex virus molecular test. The MDx HSV-1/2 runs on the Abbott m2000 platform and detects HSV viral DNA and differentiates HSV-1 and HSV-2 in male and female genital or oral lesions and cerebral spinal fluid.

Investment bank William Blair & Co. has initiated coverage of research reagents provider Techne with a Market Perform rating.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.